Jeffrey A Munsie insider trades: Concert Pharmaceuticals (CNCE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | CNCE | ↓ Sell | 3,762 | $8.34 | $31K | Direct | Feb 16, 2023 (1d) |
| Jan 30, 2023 | CNCE | ↓ Sell | 8,493 | $8.35 | $71K | Direct | Jan 31, 2023 (1d) |
| Jan 6, 2023 | CNCE | ↓ Sell | 2,893 | $7.25 | $21K | Direct | Jan 9, 2023 (3d) |
| Feb 14, 2022 | CNCE | ↓ Sell | 3,762 | $3.09 | $12K | Direct | Feb 16, 2022 (2d) |
| Jan 5, 2022 | CNCE | ↓ Sell | 2,894 | $3.20 | $9K | Direct | Jan 7, 2022 (2d) |
| Feb 16, 2021 | CNCE | ↓ Sell | 3,763 | $7.32 | $28K | Direct | Feb 17, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jeffrey A Munsie's insider trades
Jeffrey A Munsie is Chief Legal Officer at Concert Pharmaceuticals (CNCE). Since Feb 16, 2021, Jeffrey has reported no open-market purchases and 6 sales worth $172K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNCE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.